Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam

被引：0
|
作者：
Wu, Peter E. [1 ]
Leong, Derek [2 ]
机构：
[1] Univ Toronto, Toronto Gen Hosp, Div Clin Pharmacol & Toxicol, Dept Med, 200 Elizabeth St,Ste 14EN206, Toronto, ON M5G 2C4, Canada
[2] Univ Hlth Network, Div Clin Pharm, Toronto, ON, Canada
来源：
JAMA INTERNAL MEDICINE | 2018年 / 178卷 / 08期
关键词：
D O I：
10.1001/jamainternmed.2018.2930
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1137 / 1137
页数：1
相关论文
共 50 条
  • [1] Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam
    Abouelkheir, Manal
    Alsubaie, Sarah
    [J]. PEDIATRICS INTERNATIONAL, 2018, 60 (02) : 136 - 141
  • [2] Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients
    Buhlinger, Kaitlyn M.
    Fuller, Kathryn A.
    Faircloth, Cassidy B.
    Wallace, Jessica R.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (16) : 1204 - 1210
  • [3] Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime
    Navalkele, Bhagyashri
    Pogue, Jason M.
    Karino, Shigehiko
    Nishan, Bakht
    Salim, Madiha
    Solanki, Shantanu
    Pervaiz, Amina
    Tashtoush, Nader
    Shaikh, Hamadullah
    Koppula, Sunitha
    Koons, Jonathan
    Hussain, Tanveer
    Perry, William
    Evans, Richard
    Martin, Emily T.
    Mynatt, Ryan P.
    Murray, Kyle P.
    Rybak, Michael J.
    Kaye, Keith S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 64 (02) : 116 - 123
  • [4] VANCOMYCIN AND PIPERACILLIN-TAZOBACTAM COMPARED TO VANCOMYCIN AND CEFEPIME IN ACUTE KIDNEY INJURY
    Barre, Stephanie
    Samarin, Michael
    Jacobs, Anna
    Krushinski, Joseph
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [5] Does concomitant administration of Piperacillin-Tazobactam with Vancomycin really increase the incidence of acute kidney injury?
    Katchan, Lisa
    Seidel, Taylor
    Bui, Jennifer
    Younus, Faheem
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E175 - E175
  • [6] The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime
    Molina, Kyle C.
    Barletta, Jeffrey F.
    Hall, Scott T.
    Yazdani, Cyrus
    Huang, Vanthida
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (12) : 1434 - 1438
  • [7] The Effect of Vancomycin and Piperacillin-Tazobactam on Incidence of Acute Kidney Injury in Patients With Obesity
    Wuerger, Angela
    Bowden, Jarred
    Mitchell, Anna
    Marler, Jacob
    [J]. HOSPITAL PHARMACY, 2023, 58 (06) : 605 - 613
  • [8] Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem
    Blevins, Adam M.
    Lashinsky, Jennifer N.
    McCammon, Craig
    Kollef, Marin
    Micek, Scott
    Juang, Paul
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [9] Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship
    Karino, Shigehiko
    Kaye, Keith S.
    Navalkele, Bhagyashri
    Nishan, Bakht
    Salim, Madiha
    Solanki, Shantanu
    Pervaiz, Amina
    Tashtoush, Nader
    Shaikh, Hamadullah
    Koppula, Sunitha
    Martin, Emily T.
    Mynatt, Ryan P.
    Murray, Kyle P.
    Rybak, Michael J.
    Pogue, Jason M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3743 - 3750
  • [10] Risk of acute kidney injury in critically-Ill patients receiving concomitant vancomycin and piperacillin-tazobactam compared to vancomycin and cefepime
    Molina, Kyle
    Yazdani, Cyrus
    Barletta, Jeffrey
    Hall, Scott
    Huang, Vanthida
    [J]. PHARMACOTHERAPY, 2017, 37 (12): : E150 - E150
12345